 Connection
David Moreno to Mutation
This is a "connection" page, showing publications David Moreno has written about Mutation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.387 |
|
|
|
-
Moreno DF, Nadeu F, Brasó-Maristany F, Vaqué S, Paz S, Mañé J, Cardús O, Medina E, Lozano E, Rodríguez-Lobato LG, de Daniel A, Tovar N, Cibeira MT, Bladé J, Rosiñol L, Prat A, Colomer D, Fernández de Larrea C. Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P. Front Immunol. 2025; 16:1604089.
Score: 0.105
-
Moreno DF, Fernández de Larrea C. Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):659-670.
Score: 0.091
-
Moreno DF, López-Guerra M, Paz S, Oliver-Caldés A, Mena MP, Correa JG, Battram AM, Osuna M, Rivas-Delgado A, Rodríguez-Lobato LG, Cardús O, Tovar N, Cibeira MT, Jiménez-Segura R, Bladé J, Rosiñol L, Colomer D, Fernández de Larrea C. Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia. Br J Haematol. 2023 01; 200(2):187-196.
Score: 0.087
-
Moreno DF, de Larrea CF, Castillo JJ. New treatment strategies for Waldenström macroglobulinemia. Clin Adv Hematol Oncol. 2022 Aug; 20(8):506-515.
Score: 0.086
-
Castillo JJ, Moreno DF, Arbelaez MI, Hunter ZR, Treon SP. CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review. Expert Rev Hematol. 2019 10; 12(10):873-881.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|